Wei Zhao is a Nephrology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
814 Kempsville Rd
Suite 102 Bldg 17
Norfolk, VA 235024001
Telephone
757-623-0005Provider last certified this registry record 20 Jan 2022.
Clinical trials
- A Multiple Ascending Dose Study of LW402 in Healthy Volunteers
Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.
- A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
- Study of Food Effect on Pharmacokinetics of HMPL-523 Acetate Tablets
Sponsor: Hutchmed
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year202514 payments
- GlaxoSmithKline, LLC.Program year202512 payments
- Amgen Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Calcium channel blocker43.7%Amlodipine Besylate100%Part D≥57 patientsThiazide diuretic22.6%Hydrochlorothiazide100%Part D≥28 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2004–2012 per NIH RePORTER. The latest:
- Human Tissue Acquisition and Processing Core
Virginia Commonwealth University
FY2012$259,695U19AI077435 - Human Tissue Acquisition and Processing Core
Virginia Commonwealth University
FY2011$170,206U19AI077435 - Human Tissue Acquisition and Processing Core
Virginia Commonwealth University
FY2010$172,321U19AI077435
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”